Symbols / PRFX
PRFX Chart
About
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel. It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations. The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026. The company was incorporated in 2007 and is based in Tel Aviv-Yafo, Israel.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 2.26M |
| Enterprise Value | -2.26M | Income | -4.09M | Sales | — |
| Book/sh | 20.97 | Cash/sh | 8.64 | Dividend Yield | — |
| Payout | 0.00% | Employees | 2 | IPO | — |
| P/E | 0.02 | Forward P/E | -0.24 | PEG | — |
| P/S | — | P/B | 0.14 | P/C | — |
| EV/EBITDA | 0.57 | EV/Sales | — | Quick Ratio | 1.52 |
| Current Ratio | 1.59 | Debt/Eq | 0.66 | LT Debt/Eq | — |
| EPS (ttm) | 149.50 | EPS next Y | -12.06 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2024-08-15 16:00 | ROA | -36.19% |
| ROE | -127.65% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 783.07K |
| Shs Float | 384.24K | Short Float | 5.58% | Short Ratio | 0.05 |
| Short Interest | — | 52W High | 17.95 | 52W Low | 2.57 |
| Beta | 0.54 | Avg Volume | 538.26K | Volume | 42.51K |
| Target Price | — | Recom | None | Prev Close | $2.98 |
| Price | $2.89 | Change | -3.02% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
—
Mean price target
2. Current target
$2.89
Latest analyst target
3. DCF / Fair value
$-104.36
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$2.89
Low
—
High
—
Mean
—
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2024-10-24 | down | Maxim Group | Buy → Hold | — |
| 2024-06-26 | reit | Maxim Group | Buy → Buy | $2 |
- From pain drug to AI solar: PRF Technologies pivots into two big markets - Stock Titan hu, 15 Jan 2026 08
- PRF Technologies’ DeepSolar Lands First Commercial Due Diligence Deal with EDF in Israel - The Globe and Mail hu, 19 Feb 2026 08
- Data audit for Israeli solar farm: EDF taps PRF's DeepSolar - Stock Titan Wed, 18 Feb 2026 14
- PRF Technologies Ltd. (PRFX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade Wed, 05 Nov 2025 17
- PRF Technologies stock soars after securing SaaS deal for Romanian solar plant - Investing.com Nigeria Wed, 11 Feb 2026 14
- PainReform Stock Spikes As It Rebrands, Expands Beyond Pharma With AI, Clean Energy Push - Benzinga Fri, 16 Jan 2026 08
- PainReform PRFX stock jumps in premarket after company rebrands as PRF Technologies - TechStock² Fri, 16 Jan 2026 08
- PRF Technologies Secures 71 MW DeepSolar SaaS Deployment in Romania - The Globe and Mail hu, 12 Feb 2026 08
- AI system to monitor 71 MW Romanian solar farm in new PRF deal - Stock Titan Wed, 11 Feb 2026 08
- PRF Technologies Announces 1-for-5 Reverse Share Split Effective February 6, 2026 - TipRanks Fri, 06 Feb 2026 08
- PRFX Stock Gains Momentum Amid Recent Developments - StocksToTrade Wed, 05 Nov 2025 08
- PainReform (NASDAQ: PRFX) featured; DeepSolar Predict in NVIDIA Connect, pilot progress - Stock Titan Wed, 05 Nov 2025 08
- 50% Better Solar Weather Forecasting: PainReform's DeepSolar Joins Elite NVIDIA AI Program for Clean Energy - Stock Titan ue, 19 Aug 2025 07
- PainReform (Nasdaq: PRFX) validates LayerBio drop-less ocular platform for multi-drug cataract care - Stock Titan Wed, 10 Dec 2025 08
- New drop-free eye drug implant shows early safety in cataract surgery - Stock Titan Mon, 12 Jan 2026 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | 1.38K | 397.44K | -14.03K | -5.06K |
| TaxRateForCalcs | 0.23 | 0.23 | 0.23 | 0.23 |
| NormalizedEBITDA | -14.66M | -11.30M | -8.79M | -7.18M |
| TotalUnusualItems | 6.00K | 1.73M | -61.00K | -22.00K |
| TotalUnusualItemsExcludingGoodwill | 6.00K | 1.73M | -61.00K | -22.00K |
| NetIncomeFromContinuingOperationNetMinorityInterest | -14.59M | -9.34M | -8.79M | -7.25M |
| ReconciledDepreciation | 16.00K | 15.00K | 15.00K | 7.00K |
| EBITDA | -14.66M | -9.57M | -8.85M | -7.20M |
| EBIT | -14.67M | -9.58M | -8.87M | -7.21M |
| NetInterestIncome | 87.00K | -1.48M | 147.00K | -10.00K |
| InterestExpense | 0.00 | 0.00 | ||
| InterestIncome | 101.00K | 406.00K | 160.00K | 0.00 |
| NormalizedIncome | -14.59M | -10.67M | -8.75M | -7.23M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -14.59M | -9.34M | -8.79M | -7.25M |
| TotalExpenses | 14.67M | 9.58M | 8.87M | 7.21M |
| RentExpenseSupplemental | 146.00K | 191.00K | 249.00K | 210.00K |
| TotalOperatingIncomeAsReported | -14.67M | -9.58M | -8.87M | -7.21M |
| DilutedAverageShares | 148.01K | 138.55K | 41.65K | |
| BasicAverageShares | 148.01K | 138.55K | 41.65K | |
| DilutedEPS | -63.13 | -63.46 | -174.00 | |
| BasicEPS | -63.13 | -63.46 | -174.00 | |
| DilutedNIAvailtoComStockholders | -14.59M | -9.34M | -8.79M | -7.25M |
| NetIncomeCommonStockholders | -14.59M | -9.34M | -8.79M | -7.25M |
| NetIncome | -14.59M | -9.34M | -8.79M | -7.25M |
| NetIncomeIncludingNoncontrollingInterests | -14.59M | -9.34M | -8.79M | -7.25M |
| NetIncomeContinuousOperations | -14.59M | -9.34M | -8.79M | -7.25M |
| TaxProvision | 8.00K | 8.00K | 9.00K | 6.00K |
| PretaxIncome | -14.58M | -9.34M | -8.78M | -7.24M |
| OtherIncomeExpense | 6.00K | 1.73M | -61.00K | -22.00K |
| GainOnSaleOfSecurity | 6.00K | 1.73M | -61.00K | -22.00K |
| NetNonOperatingInterestIncomeExpense | 87.00K | -1.48M | 147.00K | -10.00K |
| TotalOtherFinanceCost | 14.00K | 1.89M | 13.00K | 10.00K |
| InterestExpenseNonOperating | 0.00 | 0.00 | ||
| InterestIncomeNonOperating | 101.00K | 406.00K | 160.00K | 0.00 |
| OperatingIncome | -14.67M | -9.58M | -8.87M | -7.21M |
| OperatingExpense | 14.67M | 9.58M | 8.87M | 7.21M |
| ResearchAndDevelopment | 11.71M | 6.04M | 4.42M | 2.86M |
| SellingGeneralAndAdministration | 2.97M | 3.55M | 4.45M | 4.35M |
| GeneralAndAdministrativeExpense | 2.97M | 3.55M | 4.45M | 4.35M |
| OtherGandA | 1.51M | 1.36M | 1.66M | 1.80M |
| InsuranceAndClaims | 263.00K | 394.00K | 653.00K | 935.00K |
| RentAndLandingFees | 146.00K | 191.00K | 249.00K | 210.00K |
| SalariesAndWages | 1.04M | 1.61M | 1.88M | 1.40M |
| TotalRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| OperatingRevenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 1.47M | 72.01K | 44.31K | 43.67K |
| ShareIssued | 1.47M | 72.01K | 44.31K | 43.67K |
| TotalDebt | 45.00K | 86.00K | ||
| TangibleBookValue | 1.82M | 7.24M | 11.02M | 18.08M |
| InvestedCapital | 1.82M | 7.24M | 11.02M | 18.08M |
| WorkingCapital | 1.99M | 7.39M | 11.22M | 18.26M |
| NetTangibleAssets | 1.82M | 7.24M | 11.02M | 18.08M |
| CapitalLeaseObligations | 45.00K | 86.00K | ||
| CommonStockEquity | 1.82M | 7.24M | 11.02M | 18.08M |
| TotalCapitalization | 1.82M | 7.24M | 11.02M | 18.08M |
| TotalEquityGrossMinorityInterest | 1.82M | 7.24M | 11.02M | 18.08M |
| StockholdersEquity | 1.82M | 7.24M | 11.02M | 18.08M |
| RetainedEarnings | -56.45M | -41.86M | -32.52M | -23.73M |
| AdditionalPaidInCapital | 58.27M | 49.10M | 43.45M | 41.72M |
| CapitalStock | 0.00 | 0.00 | 94.00K | 94.00K |
| CommonStock | 0.00 | 0.00 | 94.00K | 94.00K |
| TotalLiabilitiesNetMinorityInterest | 2.70M | 2.69M | 1.31M | 991.00K |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 259.00K | 281.00K | 243.00K | 234.00K |
| NonCurrentDeferredLiabilities | 259.00K | 251.00K | 243.00K | 234.00K |
| NonCurrentDeferredTaxesLiabilities | 259.00K | 251.00K | 243.00K | 234.00K |
| LongTermDebtAndCapitalLeaseObligation | 0.00 | 30.00K | ||
| LongTermCapitalLeaseObligation | 0.00 | 30.00K | ||
| CurrentLiabilities | 2.44M | 2.41M | 1.06M | 757.00K |
| CurrentDebtAndCapitalLeaseObligation | 45.00K | 56.00K | ||
| CurrentCapitalLeaseObligation | 45.00K | 56.00K | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 197.00K | 465.00K | 499.00K | 423.00K |
| PayablesAndAccruedExpenses | 2.20M | 1.89M | 565.00K | 334.00K |
| CurrentAccruedExpenses | 1.90M | 1.67M | 356.00K | 198.00K |
| Payables | 296.00K | 221.00K | 209.00K | 136.00K |
| AccountsPayable | 296.00K | 221.00K | 209.00K | 136.00K |
| TotalAssets | 4.53M | 9.93M | 12.33M | 19.07M |
| TotalNonCurrentAssets | 97.00K | 131.00K | 44.00K | 53.00K |
| NetPPE | 97.00K | 131.00K | 44.00K | 53.00K |
| GrossPPE | 97.00K | 131.00K | ||
| OtherProperties | 35.00K | 38.00K | ||
| BuildingsAndImprovements | 62.00K | 93.00K | ||
| Properties | 0.00 | 0.00 | ||
| CurrentAssets | 4.43M | 9.80M | 12.28M | 19.02M |
| OtherCurrentAssets | 310.00K | 473.00K | ||
| RestrictedCash | 10.00K | 10.00K | 10.00K | 34.00K |
| PrepaidAssets | 38.00K | 1.72M | 2.04M | 1.76M |
| Receivables | 119.00K | 45.00K | 55.00K | 218.00K |
| OtherReceivables | 119.00K | 45.00K | 55.00K | 218.00K |
| CashCashEquivalentsAndShortTermInvestments | 4.26M | 8.03M | 10.18M | 16.54M |
| OtherShortTermInvestments | 0.00 | 6.08M | 0.00 | |
| CashAndCashEquivalents | 4.26M | 8.03M | 4.10M | 16.54M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -12.63M | -6.69M | -6.46M | -6.60M |
| IssuanceOfDebt | 0.00 | |||
| IssuanceOfCapitalStock | 5.35M | 1.70M | 0.00 | 6.00M |
| CapitalExpenditure | -13.00K | -9.00K | -6.00K | -50.00K |
| EndCashPosition | 4.27M | 8.04M | 4.11M | 16.57M |
| BeginningCashPosition | 8.04M | 4.11M | 16.57M | 15.69M |
| EffectOfExchangeRateChanges | 6.00K | 2.00K | 0.00 | 0.00 |
| ChangesInCash | -3.77M | 3.93M | -12.46M | 881.00K |
| FinancingCashFlow | 8.86M | 4.62M | 0.00 | 7.48M |
| CashFlowFromContinuingFinancingActivities | 8.86M | 4.62M | 0.00 | 7.48M |
| NetOtherFinancingCharges | -1.24M | -932.00K | -446.00K | |
| ProceedsFromStockOptionExercised | 4.75M | 3.85M | 0.00 | 1.93M |
| NetCommonStockIssuance | 5.35M | 1.70M | 0.00 | 6.00M |
| CommonStockIssuance | 5.35M | 1.70M | 0.00 | 6.00M |
| NetIssuancePaymentsOfDebt | 0.00 | |||
| NetLongTermDebtIssuance | 0.00 | |||
| LongTermDebtIssuance | 0.00 | |||
| InvestingCashFlow | -13.00K | 5.99M | -6.01M | -50.00K |
| CashFlowFromContinuingInvestingActivities | -13.00K | 5.99M | -6.01M | -50.00K |
| NetInvestmentPurchaseAndSale | 0.00 | 6.00M | -6.00M | 0.00 |
| SaleOfInvestment | 0.00 | 7.00M | ||
| PurchaseOfInvestment | 0.00 | -1.00M | -6.00M | 0.00 |
| NetPPEPurchaseAndSale | -13.00K | -9.00K | -6.00K | -50.00K |
| PurchaseOfPPE | -13.00K | -9.00K | -6.00K | -50.00K |
| OperatingCashFlow | -12.62M | -6.68M | -6.46M | -6.55M |
| CashFlowFromContinuingOperatingActivities | -12.62M | -6.68M | -6.46M | -6.55M |
| ChangeInWorkingCapital | 1.66M | 1.63M | 672.00K | -538.00K |
| ChangeInOtherCurrentAssets | -348.00K | |||
| ChangeInPayablesAndAccruedExpense | 52.00K | 1.30M | 316.00K | -190.00K |
| ChangeInAccruedExpense | -24.00K | 1.29M | 243.00K | 395.00K |
| ChangeInPayable | 76.00K | 12.00K | 73.00K | -585.00K |
| ChangeInAccountPayable | 76.00K | 12.00K | 73.00K | -585.00K |
| ChangeInPrepaidAssets | 1.60M | 330.00K | 356.00K | -348.00K |
| OtherNonCashItems | -10.00K | 1.58M | 257.00K | 412.00K |
| StockBasedCompensation | 310.00K | 804.00K | 1.39M | 812.00K |
| DepreciationAmortizationDepletion | 16.00K | 15.00K | 15.00K | 7.00K |
| DepreciationAndAmortization | 16.00K | 15.00K | 15.00K | 7.00K |
| Depreciation | 16.00K | 15.00K | 15.00K | 7.00K |
| OperatingGainsLosses | -6.00K | -1.36M | ||
| GainLossOnInvestmentSecurities | -1.36M | |||
| NetForeignCurrencyExchangeGainLoss | -6.00K | -2.00K | 0.00 | 0.00 |
| NetIncomeFromContinuingOperations | -14.59M | -9.34M | -8.79M | -7.25M |
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Public Trades for PRFX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|